Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Investing

AbbVie : ABBV

All AbbVie Articles

633 Articles

Joel South | Jul 27, 2026 at 11:40 AM EDT

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

A 2.8% Social Security raise barely covers a trip to the grocery store, so retirees are quietly rebuilding their paychecks…

Michael Williams | Jul 25, 2026 at 6:46 PM EDT

Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?

Waiting until 70 to claim Social Security sounds simple until you calculate the eight years of income you need to…

Vandita Jadeja | Jul 19, 2026 at 9:30 AM EDT

3 Biggest Pharma Giants: Buy, Sell or Hold?

All three pharma giants have left the S&P 500 in the dust, but surging returns and strong fundamentals tell very…

Joel South | Jul 19, 2026 at 9:00 AM EDT

Why Johnson & Johnson Is a Stock You Can Own Forever

Most investors trade in and out of healthcare stocks chasing quarterly catalysts, but a small group of retirement portfolios quietly…

John Seetoo | Jul 17, 2026 at 12:57 PM EDT

VYM’s $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way

With 10-year Treasuries near 4.62%, VYM's $94.6 billion portfolio faces a real test from risk-free yields, and two familiar names…

Trey Thoelcke | Jul 15, 2026 at 7:45 AM EDT

AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap

AbbVie and Baxter both flashed the same bullish technical signal this month, but one golden cross signals genuine momentum while…

Joel South | Jul 13, 2026 at 8:30 AM EDT

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) is the easiest healthcare name to evaluate on the board heading into…

Vandita Jadeja | Jul 10, 2026 at 11:30 AM EDT

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JNJ and AbbVie both beat revenue expectations in Q1 2026, yet their strategies could not look more different, and which…

Joel South | Jul 8, 2026 at 11:31 AM EDT

JEPI vs. JEPQ: Which Is the Better Buy in July?

The battle between JPMorgan’s two flagship covered-call income ETFs comes down to a simple trade-off: JPMorgan Equity Premium Income ETF…

Joel South | Jul 7, 2026 at 8:00 AM EDT

3 Dividend Aristocrats to Buy in July

Dividend Aristocrats, the S&P 500 companies that have raised payouts for 25 or more consecutive years, remain the bedrock of…

Omor Ibne Ehsan | Jul 6, 2026 at 3:05 PM EDT

A 2.86% Yield, 0.08% Fee, and 75 Stocks: Is HDV the Anti-Hype ETF?

Dividend funds pulled in $24.1 billion in the first quarter of 2026, their strongest opening quarter in four years, and…

John Seetoo | Jul 5, 2026 at 1:47 PM EDT

Six Dividend Aristocrats Keeping SCHD’s Income Stream Bulletproof This Year

Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) pays a quarterly distribution from roughly 100 quality-screened U.S. dividend stocks. The fund holds…

David Beren | Jul 3, 2026 at 4:22 PM EDT

Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It.

The average Social Security retirement check reached $2,081 per month as of April 2026, according to the Social Security Administration’s…

Joel South | Jul 2, 2026 at 8:00 AM EDT

3 Dividend Stocks to Buy Hand Over Fist in July

Dividend investors entering July 2026 have a rare setup: Three of the market’s most reliable income stocks all delivered beat-and-raise…

Marc Guberti | Jul 1, 2026 at 7:55 AM EDT

MTUM Investors: Watch Micron’s Weight at the November Reconstitution

The iShares MSCI USA Momentum Factor ETF (NYSEARCA:MTUM) has run hard this year, climbing 30% year to date and 38%…

1 2 3 4 … 43

AbbVie : ABBV

All AbbVie Articles

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?

3 Biggest Pharma Giants: Buy, Sell or Hold?

Why Johnson & Johnson Is a Stock You Can Own Forever

VYM’s $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way

AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JEPI vs. JEPQ: Which Is the Better Buy in July?

3 Dividend Aristocrats to Buy in July

A 2.86% Yield, 0.08% Fee, and 75 Stocks: Is HDV the Anti-Hype ETF?

Six Dividend Aristocrats Keeping SCHD’s Income Stream Bulletproof This Year

Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It.

3 Dividend Stocks to Buy Hand Over Fist in July

MTUM Investors: Watch Micron’s Weight at the November Reconstitution

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

ServiceNow Just Ripped 29% in a Month. What Would It Take to Get NOW Stock Up to $150?

Microsoft Just Ripped 28% in a Month. What Would It Take to Get MSFT Stock Up to $600?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Clark Howard Warned Apple Traps You in Forever Leases and Now Three New Macs Just Landed

Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200?

ServiceNow Just Ripped 29% in a Month. What Would It Take to Get NOW Stock Up to $150?

AbbVie : ABBV

All AbbVie Articles

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

Claiming Social Security at 62 vs. Building a Dividend Bridge: Which Leaves You Richer at 75?

3 Biggest Pharma Giants: Buy, Sell or Hold?

Why Johnson & Johnson Is a Stock You Can Own Forever

VYM’s $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way

AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap

The Real Case for Buying Johnson & Johnson (JNJ) Before July 15

Johnson & Johnson vs AbbVie: Two Paths to Pharma Dominance, One Winner

JEPI vs. JEPQ: Which Is the Better Buy in July?

3 Dividend Aristocrats to Buy in July

A 2.86% Yield, 0.08% Fee, and 75 Stocks: Is HDV the Anti-Hype ETF?

Six Dividend Aristocrats Keeping SCHD’s Income Stream Bulletproof This Year

Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It.

3 Dividend Stocks to Buy Hand Over Fist in July

MTUM Investors: Watch Micron’s Weight at the November Reconstitution

Live: Will Semtech’s Q2 Earnings Tonight Send Its Stock Higher?

Live: Will Intuit’s Q4 Earnings Tonight Extend the Stock’s 25% Rebound?

Live: Will Zoom Crush Tonight’s Q2 Earnings After the Bell?

ServiceNow Just Ripped 29% in a Month. What Would It Take to Get NOW Stock Up to $150?

Microsoft Just Ripped 28% in a Month. What Would It Take to Get MSFT Stock Up to $600?

Wall Street Just Invented the ‘Neocloud’ ETF. It Owns the Companies Renting AI Compute to Everyone Else

Featured Reads

You Saved for 40 Years. 48% of Retirees Have No Plan for Spending It. Here's What a Plan Looks Like.

Clark Howard Warned Apple Traps You in Forever Leases and Now Three New Macs Just Landed